Does CLASCOTERONE Cause Product dose omission issue? 129 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Product dose omission issue have been filed in association with CLASCOTERONE (Winlevi). This represents 11.7% of all adverse event reports for CLASCOTERONE.
129
Reports of Product dose omission issue with CLASCOTERONE
11.7%
of all CLASCOTERONE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product dose omission issue From CLASCOTERONE?
Of the 129 reports.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLASCOTERONE. However, 129 reports have been filed with the FAERS database.
What Other Side Effects Does CLASCOTERONE Cause?
Product physical consistency issue (317)
Product use complaint (285)
Product storage error (258)
Product use issue (110)
Drug ineffective (109)
Product physical issue (76)
Therapy cessation (75)
Poor quality product administered (62)
Product quality issue (61)
Condition aggravated (44)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which CLASCOTERONE Alternatives Have Lower Product dose omission issue Risk?
CLASCOTERONE vs CLAVULANATE
CLASCOTERONE vs CLAVULANIC ACID
CLASCOTERONE vs CLEMASTINE
CLASCOTERONE vs CLENBUTEROL
CLASCOTERONE vs CLEVIDIPINE